CDTXbenzinga

HC Wainwright & Co. Maintains Buy on Cidara Therapeutics, Raises Price Target to $35

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 10, 2025 by benzinga

    HC Wainwright & Co. Maintains Buy on Cidara Therapeutics, Raises Price Target to $35 | CDTX Stock News | Candlesense